Breaking News

Avantor Opens New Single-Use Facility in The Netherlands

Significantly expands the company's overall cleanroom capacity in the region, servicing regional and global customers.

By: Kristin Brooks

Managing Editor, Contract Pharma

Avantor, Inc., a global provider of products and services to the life sciences, advanced technologies and applied materials industries, has opened a new single-use facility in Hillegom, Netherlands in early October 2021. The site is Avantor’s second single-use location in Europe after its Tilburg, Netherlands site and is a significant addition to the company’s overall cleanroom capacity in the region, servicing regional and global customers.
 
Located between Amsterdam and Leiden in the industrial corridor of the Netherlands, the Hillegom facility enables Avantor to manufacture, package and deliver single-use solutions that support all stages of biologics manufacturing including upstream, downstream and fill-finish.
 
“We continue to grow our single-use footprint and capabilities to serve the needs of the global biopharma industry,” said Dr. Ger Brophy, Executive Vice President of Biopharma Production at Avantor. “We are proud to be part of the Hillegom community and boost our presence in the Netherlands. Opening this site also reflects our commitment to support the growing demand for speed and efficiency in bioproduction. This facility will enhance the regional single-use supply chain in Europe, and Avantor looks forward to continuing to grow our business in this important market.”
 
Avantor’s global single-use footprint also includes multiple sites in the U.S. as well as a site in Changzhou, China that was acquired as part of the company’s recent acquisition of RIM Bio. Additionally, Avantor recently announced its intent to acquire Masterflex, a global manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies, which will strengthen its offering across all bioproduction platforms.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters